In this Clinical Conversations newsletter, Dr Scott Boswell shares how reframing prurigo nodularis (PN) and atopic dermatitis (AD) as neuroimmune-driven conditions has shaped his clinical philosophy. He shares his 3‑step approach to patient communication, highlights real‑world treatment journeys in PN and AD, and reflects on the impact of targeting IL‑31RA with NEMLUVIO® on managing chronic itch and supporting skin healing in appropriate patients.
Clinical Conversations: Discover Dr J Scott Boswell’s Perspective on Redefining PN and AD Through a Neuroimmune Lens
03/24/2026
Choose a format
Details
